Current Studies

Los Angeles Clinical Trials

Ventura Clinical trials (VCC) is at the forefront of drug development, founded by Leading experts in Gastroenterology and Cardiology. It is a physician-owned company with over 23 years of experience in clinical trials.

VCC brings together board certified physicians, Ventura patients from our large database, regulatory personnel , nurses, pharmacists, psychologists, nutritionists, highly experienced clinical research coordinators and highly specialized support technicians. Based in Ventura but with offices in Westlake and Malibu, our facilities have state of the art equipment.

We conduct phase I to IV studies and have access to private endoscopy centers, cardiac centers, pathology centers as well as radiology. We are also affiliated with 2 community hospitals and provide a 48 hour turn around for IRB approval as well as trial and budget approval.

Our regulatory team as well as our recruiting team has been amongst the first in previous studies in study start–up and finishing time.

Our Quality assurance department and performance allows you to make great decisions about your product.

please Call 1 866 947 6815 for more information about our studies

Los Angeles Clinical Trials

Clearing the path to lower cholesterol

Your patients with, or at high risk for, cardiovascular disease may be able to participate in the CLEAR program

The CLEAR Program includes four randomized, double-blind, placebo-controlled studies to assess the effects of bempedoic acid on endpoints related to cardiovascular disease and its associated risks. Approximately 15,000 patients from across the world will take part.

The CLEAR Program will assess the effect of bempedoic acid on the risk of major adverse cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant.

The CLEAR Program will determine whether bempedoic acid can help to lower LDL-C levels in patients with elevated LDL-C levels who are statin intolerant.

The CLEAR Wisdom Study will assess the efficacy of bempedoic acid for lowering LDL-C levels in patients with high cardiovascular risk with hyperlipidemia  (with underlying heterozygous familial hypercholesterolemia and/or atherosclerotic cardiovascular diseases).

The Clear Tranquility Study will evaluate bempedoic acid as an add-on to tzetimibe therapy in patients with elevated LDL-C.

please Call 1 866 947 6815 for more information

 

 

Los Angeles Clinical Trials
Fatty Liver study please call
1 866 947 6815

Have you be told that you have fatty liver or NASH?

Do you have at least two of the following conditions?

– Type 2 Diabetes

– High blood pressure

– Obesity (BMI of at least 34)

– Elevated liver enzymes (high ALT or AST)

If so, you may qualify for a study in patients who have non-alcoholic steatohepatitis, or NASH. NASH is considered a silent disease as it often has no symptoms and is a leading cause of cirrhosis.

There is currently no FDA approved treatment for NASH.

We are conducting a clinical research trial to investigate the safety and effectiveness of an investigational medication to treat NASH. Searching for participation by men and women 18 years or older who are suspected to have NASH.

If you qualify, you will receive study-related:

– Medication

– Laboratory tests Compensation for time and travel

– Diagnostic procedures

– Physical exams

For more information please call 1 866 947 6815

 

Los Angeles Clinical Trials

Are you feeling anxious, withdrawn, or depressed?

It’s not your fault

Postpartum Depression is a biological complication of pregnancy.

Symptoms can be severe and shouldn’t be ignored.

The Hummingbird Study is a research study evaluating an investigational medication in women with moderate to severe postpartum depression.

You May Qualify to Participate if you:

  • Are between 18 to 45 years old
  • Gave birth within the last 6 months
  • Frequently feel extremely sad, anxious, or overwhelmed and these symptoms are associated with postpartum depression.

The study doctor will discuss other requirements.

IF YOU QUALIFY AND DECIDE TO PARTICIPATE, YOU WILL RECEIVE:

  • Study-related care during the 3-day, in-patient period
  • All study-related medical care and medication at no cost
  • Transportation may be provided for those who require assistance

For more information on Postpartum Depression please call 1 866 947 6815

 

 

Los Angeles Clinical Trials

Have your or a loved one received care for memory impairment?

A research study is being conducted to gather information about caring for patients diagnosed with Mild Cognitive Impairment or Mild Dementia due to Alzheimer’s Disease.

Patients may qualify for the study if they:

  • Are between 55 and 85 years old
  • Have a reliable family member or friend willing to serve as a study partner and attend all study visits.

If you choose to participate in this study, you will help us to collect information that may help others affected by Alzheimer’s disease in the future.

For more information please call 1 866 947 6815

 

Los Angeles Clinical Trials

Do you have a Mirena IUD?

Are you scheduled to get your Mirena removed in 2017?
You may qualify for a study on the extended use of Mirena IUD!

Women 18-35 years old, currently using Mirena for at least 4.5 years and still requiring contraception may be eligible to participate and may receive

– Compensation up to $800

– Related health care at no cost

For more information please call 1 866 947 6815

 

Los Angeles Clinical Trials

For more information please call 1 866 947 6815

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save